Guernsey's life-saving cholesterol screening earns national award nomination

Guernsey's Familial Hypercholesterolemia (FH) screening service has been shortlisted for a national award in public health innovation. The programme, running since 2018, has already diagnosed 55 patients through blood tests, genetic checks, and family follow-ups. Free testing and support will now continue for another three years, thanks to private funding from a benefactor.

Familial Hypercholesterolemia is an inherited condition causing dangerously high cholesterol from birth. Without treatment, it raises the risk of early heart attacks and cardiovascular disease. Since its launch, the Guernsey service has identified 40% of the island's estimated FH cases.

The initiative's success has earned it a nomination at the General Practice Awards. Staff from the FH clinic and Queens Road Medical Practice will attend the ceremony in London on 5 December. Rob Jordan, Practice Manager at Queens Road, highlighted the achievement as a milestone for Guernsey's healthcare team. Dr Mat Dorrian, FH Clinic Lead, suggested the programme could serve as a model for other regions. However, no details are available on whether similar schemes have been adopted in England, Scotland, or Wales.

The screening service has provided genetic diagnoses for dozens of patients while securing long-term funding. Its recognition at the national awards reflects its impact on preventative care. The team's work may now influence broader healthcare strategies beyond Guernsey.